¸Û²Ê¿ª½±

Pharmacists urged to advise patients with prescriptions for Orencia (abatacept) to speak to their specialists as shortages hit  Bristol-Myers Squibb Australia (BMS) has advised the Therapeutic Goods Administration (TGA) that both its Orencia 125mg/mL ClickJect autoinjector and prefilled syringe subcutaneous products are now in short supply.  The company had previously anticipated that shortages to the